Literature DB >> 7525058

Current approaches to targeting cancer using antiangiogenesis therapies.

P A Scott1, A L Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7525058     DOI： 10.1016/0305-7372(94)90020-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  13 in total

Review 1.  New prognostic factors in resectable non-small cell lung cancer.

Authors:  E F Smit; H J Groen; T A Splinter; T Ebels; P E Postmus
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

2.  MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.

Authors:  F Guddo; A Giatromanolaki; M I Koukourakis; C Reina; A M Vignola; G Chlouverakis; J Hilkens; K C Gatter; A L Harris; G Bonsignore
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

3.  Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression.

Authors:  Tae Hyong Kim; Sookyung Ahn; Jaebeum Kim; Ilhan Kim; Mei Zi Yang; Jong Eun Lee; Soung Soo Kim
Journal:  Clin Exp Metastasis       Date:  2006-12-23       Impact factor: 5.150

Review 4.  Current and future strategies to block tumor angiogenesis, invasion, and metastasis.

Authors:  P J Effert; G Gastl; T Strohmeyer
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Evaluation of recombinant endostatin in the treatment of atherosclerotic plaques and neovascularization in rabbits.

Authors:  Wei Mao; Jing Kong; Jin Dai; Zhao-quan Huang; Dong-zhi Wang; Gui-bao Ni; Min-li Chen
Journal:  J Zhejiang Univ Sci B       Date:  2010-08       Impact factor: 3.066

Review 6.  Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Authors:  J P Crew; T S O'Brien; A L Harris
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 7.  [Urine-based markers of angiogenesis in bladder cancer].

Authors:  M Becker; D Tilki; T Szarvas; H Rübben; S Ergün
Journal:  Urologe A       Date:  2009-06       Impact factor: 0.639

8.  Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma.

Authors:  Leo L Tsai; Rupal S Bhatt; Meaghan F Strob; Opeyemi A Jegede; Maryellen R M Sun; David C Alsop; Paul Catalano; David McDermott; Philip M Robson; Michael B Atkins; Ivan Pedrosa
Journal:  Radiology       Date:  2020-12-01       Impact factor: 11.105

Review 9.  Radionuclide carriers for targeting of cancer.

Authors:  Stavroula Sofou
Journal:  Int J Nanomedicine       Date:  2008

10.  Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

Authors:  M I Koukourakis; A Giatromanolaki; S Kakolyris; K J O'Byrne; N Apostolikas; J Skarlatos; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.